Structural basis of cell surface receptor recognition by botulinum neurotoxin B

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature

• Publication date

  2006-12-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nature05411PMID 17167418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SV2 Is the Protein Receptor for Botulinum Neurotoxin A

  2006cited by this paper
• The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

  2006cited by this paper
• Common binding site for disialyllactose and tri‐peptide in C‐fragment of tetanus neurotoxin

  2005cited by this paper
• Role of metals in the biological activity of Clostridium botulinum neurotoxins.

  2004cited by this paper
• Substrate recognition strategy for botulinum neurotoxin serotype A

  2004cited by this paper
• Crystallographic identification of Ca2+ and Sr2+ coordination sites in synaptotagmin I C2B domain

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G*

  2004cited by this paper
• Identification of the major steps in botulinum toxin action.

  2004cited by this paper
• The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction

  2003cited by this paper
• Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells

  2003cited by this paper
• Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.

  2003cited by this paper
• Botulinum Neurotoxin A Activity Is Dependent upon the Presence of Specific Gangliosides in Neuroblastoma Cells Expressing Synaptotagmin I*

  2002cited by this paper
• The Crystal Structure of Tetanus Toxin Hc Fragment Complexed with a Synthetic GT1b Analogue Suggests Cross-linking between Ganglioside Receptors and the Toxin*

  2001cited by this paper
• Structure‐based sequence alignment for the β‐trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site

  2000cited by this paper
• Neurotoxins affecting neuroexocytosis.

  2000cited by this paper
• Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs.

  2000cited by this paper
• Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B

  2000cited by this paper
• Crystal Structure of the Cytosolic C2a-C2b Domains of Synaptotagmin III

  1999cited by this paper
• Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice.

  1999cited by this paper
• Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.

  1998cited by this paper
• Crystal structure of botulinum neurotoxin type A and implications for toxicity

  1998cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• MOLREP: an Automated Program for Molecular Replacement

  1997cited by this paper
• Cell-surface carbohydrate recognition by animal and viral lectins.

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA.

  1996cited by this paper
• The high‐affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a

  1996cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• How do tetanus and botulinum toxins bind to neuronal membranes

  1986cited by this paper

• Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells

  2026cites this paper
• Structure of the complete 14-subunit botulinum neurotoxin B complex reveals a unique anchoring through the narrow central pore of HA70

  2025cites this paper
• In Silico Study of Membrane-Inserted Synaptotagmin Conformational Changes in Complex with Botulinum Toxin B1

  2025cites this paper
• Development of a Recombinant Fusion Vaccine Candidate Against Lethal Clostridium botulinum Neurotoxin Types A and B

  2025cites this paper
• Comparative Phylogenetic Analysis and Protein Prediction Reveal the Taxonomy and Diverse Distribution of Virulence Factors in Foodborne Clostridium Strains

  2024cites this paper
• Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin protein

  2024influential citation
• Neuronal Membrane-Derived Nanodiscs for Broad-Spectrum Neurotoxin Detoxification.

  2024cites this paper
• Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature

  2024cites this paper
• Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A

  2024cites this paper
• Structure and activity of botulinum neurotoxin X

  2023cites this paper
• Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons

  2023cites this paper
• Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2

  2023cites this paper
• Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A: In Silico Studies at the Periphery of a Lipid Raft

  2022cites this paper
• Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex

  2021cites this paper
• Multiplicity of Glycosphingolipid-Enriched Microdomain-Driven Immune Signaling

  2021cites this paper
• Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM

  2021cites this paper
• Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins

  2021cites this paper
• Special Delivery: Potential Mechanisms of Botulinum Neurotoxin Uptake and Trafficking within Motor Nerve Terminals

  2020cites this paper
• Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors

  2020cites this paper
• The Glycine max Conserved Oligomeric Golgi (COG) Complex Functions During a Defense Response to Heterodera glycines

  2020cites this paper
• Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins

  2020cites this paper
• Region-specific characterization of N-glycans in striatum and substantia nigra of an adult rodent brain.

  2020cites this paper
• The 25 kDa HCN Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity

  2020influential citation
• Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy

  2020cites this paper
• Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins

  2019cites this paper
• Botulinum and Tetanus Neurotoxins.

  2019cites this paper
• Synaptotagmin binding to botulinum neurotoxins.

  2019cites this paper
• The Structure and Classification of Botulinum Toxins.

  2019cites this paper
• Structural Insights Into The Interaction Of Botulinum Neurotoxin A With Its Neuronal Receptor SV2C.

  2019cites this paper
• Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B

  2019influential citation
• Botulinum Neurotoxin Diversity from a Gene-Centered View

  2018cites this paper
• Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity

  2018cites this paper
• Mechanisms of clostridial toxin binding and translocation

  2018cites this paper
• A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency

  2018cites this paper
• Variability of Botulinum Toxins: Challenges and Opportunities for the Future

  2018cites this paper
• Discovery of novel bacterial toxins by genomics and computational biology

  2018cites this paper
• Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics

  2018cites this paper
• Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding

  2018cites this paper
• Therapeutic Approaches of Botulinum Toxin in Gynecology

  2018cites this paper
• Crystal structures of OrfX2 and P47 from a Botulinum neurotoxin OrfX‐type gene cluster

  2017cites this paper
• Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domain

  2017cites this paper
• Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells

  2017cites this paper
• Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors

  2017cites this paper
• Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.

  2017cites this paper
• Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC

  2017cites this paper
• Glycans Confer Specificity to the Recognition of Ganglioside Receptors by Botulinum Neurotoxin A.

  2017cites this paper
• Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor

  2017cites this paper
• Bacterial Signaling to the Nervous System through Toxins and Metabolites.

  2017cites this paper
• Vaccines against Botulism

  2017cites this paper
• Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

  2017cites this paper
• Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems

  2017cites this paper
• Newly identified relatives of botulinum neurotoxins shed light on their molecular evolution

  2017cites this paper
• N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A

  2016cites this paper
• Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin

  2016cites this paper
• Components of the SNARE-containing regulon are co-regulated in root cells undergoing defense

  2016cites this paper
• The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain

  2016cites this paper
• Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall

  2016cites this paper
• Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins

  2016cites this paper
• Creating recombinant fusion protein conjugates for targeting SNARE protease into neuroendocrine cells

  2016cites this paper
• Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 – 2014)

  2015cites this paper
• Chapter 57 – Clostridium botulinum and Associated Neurotoxins

  2015cites this paper
• Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B

  2015cites this paper
• Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

  2015influential citation
• Heat-Labile Enterotoxin IIa, a Platform To Deliver Heterologous Proteins into Neurons

  2015cites this paper
• Infectious Diseases of the Nervous System

  2015cites this paper
• The C-Terminal Heavy-Chain Domain of Botulinum Neurotoxin A Is Not the Only Site That Binds Neurons, as the N-Terminal Heavy-Chain Domain Also Plays a Very Active Role in Toxin-Cell Binding and Interactions

  2015cites this paper
• Engineering of botulinum neurotoxins as novel therapeutic tools

  2015cites this paper
• Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery.

  2015cites this paper
• Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity

  2015cites this paper
• The long journey of botulinum neurotoxins into the synapse.

  2015cites this paper
• Synaptotagmin II and Gangliosides Bind Independently with Botulinum Neurotoxin B but Each Restrains the Other

  2014cites this paper
• High Sensitivity Detection of Active Botulinum Neurotoxin by Glyco-Quantitative Polymerase Chain-Reaction

  2014cites this paper
• Engineered botulinum neurotoxins as new therapeutics.

  2014cites this paper
• Botulinum neurotoxins: new questions arising from structural biology.

  2014cites this paper
• Current strategies for designing antidotes against botulinum neurotoxins

  2014cites this paper
• Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A

  2014cites this paper
• The Dual-Receptor Recognition of Botulinum Neurotoxins

  2014cites this paper
• Botulinum Neurotoxins from Clostridium botulinum

  2014cites this paper
• Botulinum neurotoxins: genetic, structural and mechanistic insights

  2014cites this paper
• Identification of Small Molecules against Botulinum Neurotoxin B Binding to Neuronal Cells at Ganglioside GT1b Binding Site with Low to Moderate Affinity

  2014cites this paper
• Nidogens are therapeutic targets for the prevention of tetanus

  2014cites this paper
• Molecular Aspects of Botulinum Neurotoxin

  2014influential citation
• Prevention and Treatment of Botulism

  2014cites this paper
• Translocation, Entry into the Cell

  2014cites this paper
• Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons.

  2013cites this paper
• Structure of dual receptor binding to botulinum neurotoxin B

  2013cites this paper
• Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

  2013influential citation
• Molecular assembly of botulinum neurotoxin progenitor complexes

  2013cites this paper
• Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons

  2013cites this paper
• The entry of tetanus and botulinum neurotoxins into neurons

  2013cites this paper
• Structure-based drug discovery for botulinum neurotoxins.

  2013cites this paper
• Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT/A)

  2013cites this paper
• Botulinum neurotoxins.

  2013cites this paper
• Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.

  2013cites this paper
• Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.

  2013influential citation
• Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.

  2013cites this paper
• Bacillus cereus sphingomyelinase recognizes ganglioside GM3.

  2013cites this paper
• Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.

  2013cites this paper
• Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.

  2013cites this paper
• Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.

  2013cites this paper